Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06541652 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Study acronym: FFCD-2205
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 5, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites revised (40)v3
  2. Study sites: 29 to 40v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this French multicenter retrospective study is to describ rare primary hepatic cancers clinical, histological and radiological features, to obtain a biological tumor and blood collection, and to evaluate the efficacy of treatments received in clinical practice in order to determine optimal therapeutic sequences. This retrospective cohort will be the backbone of future translational studies aimed at identifying new molecular, histological, circulating and radiological tumor biomarkers, potentially useful at every stage of diagnosis and prognostic or theranostic evaluation.
Trial Details
NCT Number NCT06541652
Lead Sponsor Federation Francophone de Cancerologie Digestive
Collaborators: Société Nationale Française de Gastroentérologie
Conditions
(from sponsor)		 Hepatocholangiocarcinoma, Fibrolamellar Carcinoma, Hepatic Epithelioid Hemangioendothelioma, Hepatoblastoma, Hepatic Neuroendocrine Carcinoma, Hepatic Carcinosarcomas, Hepatic Cystadenoma, Hepatic Leiomyosarcomas +2 more
Related terms Cholangiocarcinoma, Fibrolamellar hepatocellular carcinoma, Hepatoblastoma, Liver Neoplasms
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov